Salesforce, Inc. (CRM), the enterprise software and customer relationship management (CRM) giant, has been at the center of a sharp Wall Street debate over whether artificial intelligence will strengthen or undermine its business. That debate has produced one of the widest ranges of analyst price targets in large-cap software, making the question of a $280 stock price target particularly instructive.
More than 50 analysts actively cover Salesforce, and their targets form a strikingly broad band from roughly $160 to $475. The arithmetic mean of the recent, individually attributed targets reviewed sits near $283, which rounds to a clean central target of $280.
The most consequential recent move came from Bank of America's Tal Liani, who upgraded Salesforce two notches, from Underperform to Buy, on October 12, 2026, and lifted his target to $285 from $160. Liani reversed his prior concern that AI agents would let customers bypass software vendors, arguing instead that AI should "deepen dependence" on platforms that hold enterprise data and workflows.
Other current targets illustrate the spread. Bullish firms cluster in the high $280s to $315 range: Yorkville Ives ($290), Evercore ISI ($290), Stephens ($289), Mizuho ($280), Jefferies ($300), TD Cowen ($300), Canaccord Genuity ($300), Morgan Stanley ($315), and Citizens JMP ($315). More cautious names sit near or below the central target, including Barclays ($276), Goldman Sachs ($271), Oppenheimer ($275), Monness ($266), JPMorgan ($265), Citi ($263), UBS ($260), and Wells Fargo ($250). The $475 high and $160 low reflect genuine, durable disagreement rather than data-entry noise.
At a last close near $233.92, Salesforce trades well below its 52-week high of $269.11 and well above its 52-week low of $146.32. Reaching $280 would require a move of roughly 20%, a substantial but not extreme gain that is well within the range of the stock's recent volatility.
The path hinges on valuation as much as on fundamentals. Salesforce trades near a P/E (price-to-earnings) ratio in the low-20s, below its own multi-year historical average. Bank of America's higher target rests largely on a multiple expansion to about 16 times estimated calendar-2027 free cash flow, versus the 9 times it previously assumed. If revenue growth accelerates, a re-rating toward $280 becomes more plausible; if growth stays near the 9.6% recorded in fiscal 2026, the stock may remain anchored at a lower multiple.
Salesforce's AI strategy is the central pillar of the bull case. Its autonomous agent platform, Agentforce, surpassed $1.5 billion in annual recurring revenue in fiscal Q2 2027, up more than 240% year over year. Management has reported that net new annual order value growth was the strongest in four years, with attrition near historic lows and improving Slack performance.
Fundamentals are also firming. Second-quarter revenue rose about 11% to $11.35 billion, free cash flow jumped roughly 81% to $1.1 billion, and the company raised its full-year revenue guidance. Salesforce generated more than $15 billion in levered free cash flow over the trailing twelve months, underpinning a modest valuation premium in the eyes of several analysts.
The most cited risk is that AI revenue remains small relative to Salesforce's total. The roughly $1.5 billion Agentforce run-rate equals only about 3% to 4% of trailing revenue, and its contribution to reported sales remains modest. If AI adoption slows or if enterprises prove willing to substitute cheaper standalone tools, the multiple expansion embedded in higher targets may not materialize.
Slower macro conditions, a pullback in enterprise software spending, and valuation compression across the technology sector could also weigh on the shares. Several analysts hold targets at or below the current price precisely because they doubt that growth will reaccelerate enough to justify a higher multiple.
Salesforce has rebounded off its 50-day moving average and its 10-week line after the Bank of America upgrade, breaking a short-term downtrend. The $269 area, near the 52-week high, is a key resistance level that the stock would need to clear before $280 becomes attainable. On the downside, the mid-2026 low and the $230 zone represent support levels that have held through recent selling pressure.
Analyst price targets generally reflect a research horizon of about 12 months, though individual firms differ. The key catalysts to watch include the next quarterly earnings report, updates on Agentforce adoption and pricing, net new annual order value trends, and any further analyst target revisions. Guidance on revenue growth and free cash flow will be especially important given that the bull case rests heavily on a re-rating tied to growth acceleration.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and spot changing trends more efficiently than through manual screening. For those tracking whether CRM can reach its price target, the tool offers a data-driven way to stay ahead of evolving momentum.
The $280 target for Salesforce is a reasonable, evidence-based summary of current analyst expectations, representing roughly 20% upside from the latest price. It is supported by a meaningful Bank of America upgrade, early AI monetization, strong cash generation, and improving order trends. It is tempered by the small scale of AI revenue today, the risk of slower growth, and an unusually wide analyst range from $160 to $475. Whether the stock reaches $280 depends most on whether AI can lift total revenue growth and justify a higher valuation multipleādevelopments that will become clearer over the next several quarterly reports.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CRM has been closely correlated with NOW. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRM jumps, then NOW could also see price increases.
| Ticker / NAME | Correlation To CRM | 1D Price Change % | ||
|---|---|---|---|---|
| CRM | 100% | -0.75% | ||
| NOW - CRM | 79% Closely correlated | -4.15% | ||
| HUBS - CRM | 77% Closely correlated | -1.96% | ||
| ADBE - CRM | 75% Closely correlated | +0.85% | ||
| WDAY - CRM | 75% Closely correlated | +1.21% | ||
| FRSH - CRM | 71% Closely correlated | -1.93% | ||
More | ||||
| Ticker / NAME | Correlation To CRM | 1D Price Change % |
|---|---|---|
| CRM | 100% | -0.75% |
| CRM (13 stocks) | 77% Closely correlated | -0.71% |
| Technology Services (397 stocks) | 14% Poorly correlated | -1.91% |
| Packaged Software (222 stocks) | 13% Poorly correlated | -2.04% |